[1,3]OXAZINES Russian patent published in 2016 - IPC C07D413/12 A61K31/5355 A61P25/28 

Abstract RU 2599256 C2

FIELD: pharmaceutics.

SUBSTANCE: invention relates to a compound of formula I or its pharmaceutically acceptable salts thereof. Compound of formula (I) possess the properties of BACE1 and/or BACE2. In formula I:

R1 represents a 6-member heteroaryl containing 2 heteroatoms selected from N substituted with a substitute C2-6-alkynyl-C-1-6-alkoxy; R2 is a halogen atom; R3 is C1-6-alkyl; R4 is selected from a halogen atom; R5 is selected from a halogen atom; R6 is selected from a hydrogen atom, and R7 is selected from a hydrogen atom. Invention also relates to a tritium labelled compound of formula Ia, 11C-labelled compound of formula Ia', structural formulae are given in the claim, to a method for diagnostic imaging BACE1 enzyme, use of compounds when preparing the composition for diagnostic imaging BACE1, to a pharmaceutical composition, use of compounds in preparing a drug, to a method of inhibiting activity BACE1 and/or BACE2.

EFFECT: obtaining novel compounds of formula I possessing the properties of BACE1 and/or BACE2.

33 cl, 7 tbl, 9 ex

Similar patents RU2599256C2

Title Year Author Number
2-AMINO-5,5-DIFLUORO-5,6-DIHYDRO-4H-OXAZINES AS BACE1 AND(OR) BACE2 INHIBITORS 2010
  • Behnner Dehvid
  • Guba Vol'Fgang
  • Khil'Pert Khans
  • Mauzer Kharal'D
  • Majveg Aleksander F.
  • Narkizan Rober
  • Pinar Ehmmanjuehl'
  • Pover Ehojn
  • Rodzhers-Ehvans Mark
  • Voltering Tomas
  • Vostl' Vol'Fgang
RU2515221C2
N-[3-(5-AMINO-3,3A,7,7A-TETRAHYDRO-1H-2,4-DIOXA-6-AZA-INDEN-7-YL)-PHENYL]-AMIDES AS INHIBITORS OF BACE1 AND(OR) BACE2 2012
  • Khilpert Khans
  • Khumm Roland
RU2597308C2
2, 5, 6, 7-TETRAHYDRO-[1, 4]OXAZEPIN-3-YLAMINES OR 2, 3, 6, 7-TETRAHYDRO-[1, 4]OXAZEPIN-5-YLAMINES 2011
  • Behnner Dehvid
  • Guba Vol'Fgang
  • Khil'Pert Khans
  • Khumm Roland
  • Mauzer Kharal'D
  • Majveg Aleksander F.
  • Narkizan Rober
  • Pover Ehojn
  • Rodzhers-Ehvans Mark
  • Rombakh Did'E
  • Voltering Tomas
  • Vostl' Vol'Fgang
RU2570796C2
CONDENSED TRIAZOLAMINES AS P2X7 MODULATORS 2010
  • Kristin Brazerton-Plejss
  • Ralf N'Ju Kharris Iii
  • Brehdli Eh. Lo
  • Fransisko-Khav'Er Lopes-Tapija
  • Pankadzh D. Rege
  • Dejvid Brjus Repke
  • Rassel Stiven Stabler
  • Kejt Adrian Marri Uolker
RU2533122C2
CAMPTOTHECIN ANALOGS, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF 1997
  • Bigg Deni
  • Lavern' Oliv'E
  • Kharnett Dzherri
  • Rollan Alan
  • Liberator Ann-Mari
  • Lanko Kristof
RU2190613C2
BETA-SECRETASE INHIBITORS 2016
  • Bartels Bern
  • Dolente Kozimo
  • Guba Volfgang
  • Khaap Volfgang
  • Obst Zander Ulrike
  • Peters Jens-Uve
  • Voltering Tomas
RU2712272C2
NEW BICYCLIC COMPOUNDS OF THIOPHENYLAMIDE 2013
  • Byuttelmann Bernd
  • Chekkarelli Simona M.
  • Kyune Kholger
  • Kun Bernd
  • Najdkhart Verner
  • Obst Zander Ulrike
  • Rikhter Khans
RU2644565C2
BICYCLIC NITROIMIDAZOLES COVALENTLY CONNECTED TO REPLACED PHENYLOXAZOLYDINONES 2009
  • Ding Charl'Z Z.
  • Lu Gehn'Ljan
  • Kombrink Kit
  • Chehn' Djan'Tszjun'
  • Song Minzoo
  • Van Tszjan'Chehn
  • Ma Zhenkun
  • Palmer Brajan Desmond
  • Blejzer Ehdrian
  • Tompson Ehndrju M.
  • Kmentova Iveta
  • Saterlehnd Khamish Skott
  • Denni Uill'Jam Aleksandr
RU2504547C2
PYRAZOLAMINOPIRIMIDINE DERIVATIVES AS LEUCINE-REPEATING KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON DISEASE 2013
  • Bejker-Glenn Charlz
  • Chan Brajan K.
  • Dotson Dzhennafer
  • Estrada Entoni
  • Kheffron Timoti
  • Lissikatos Dzhozef
  • Svini Zakari Kevin
RU2637948C2
COMBINED TREATMENT BY A TOLL-LIKE RECEPTOR (TLR7) AGONIST AND A HEPATITIS B VIRUS CAPSID ASSEMBLY INHIBITOR 2016
  • Daj, Lue
  • Gao, Lu
RU2718917C2

RU 2 599 256 C2

Authors

Borroni Edilio

Gobbi Luka

Khilpert Khans

Khoner Mikhel

Muri Diter

Narkizan Rober

Polara Alessandra

Dates

2016-10-10Published

2012-06-04Filed